olpasiran
amgen
['dose,study', 'ocean', 'olpasiran', 'cardio']
olpasiran, a small interfering rna agent directed to the liver, yielded substantial and sustained reductions in lp(a) concentrations patients with ascvd in the phase 2 ocean(a)-dose study #aha22 #cardiotwitter 
The content you need, when you need it.